Evidence map›Paper›PMID 33878802›Full record

ArticleThe Journal of physiology2021

Late gestation fetal hyperglucagonaemia impairs placental function and results in diminished fetal protein accretion and decreased fetal growth.

Sarah N Cilvik, Stephanie R Wesolowski, Russ V Anthony, Laura D Brown, Paul J Rozance

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 25 citations in OpenAlex.

  1. Bernard was right about the placenta.The Journal of physiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Subcutaneous Buprenorphine Is an Acceptable Preoperative Analgesic in Pregnant Ewes Undergoing Hysterotomy (Ovis aries).Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article
  7. Fetal nutrient flux and oxidative metabolism during hypoxia: adaptive responses to defend fetal growth.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sarah N CilvikWake Forest University Health Sciences, Winston-Salem, NC, 27157, USA.ORCID 0000-0003-4673-1186
Stephanie R WesolowskiUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Russ V AnthonyColorado State University College of Veterinary Medicine, Fort Collins, CO, USA.
Laura D BrownUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-0292-5029
Paul J RozanceUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
University of Colorado Anschutz Medical Campus · USColorado State University · USWake Forest University · US

Funding

Training Program in Perinatal Biology and MedicineT32HD007186 · NICHD · UNIVERSITY OF COLORADO DENVER · PI Paul Joseph Rozance · 1985 to 2026
$6.5M
Nutrient Coordination of Pancreatic Vasculature and Beta-CellsR01DK088139 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI ROZANCE, PAUL JOSEPH · 2011 to 2020
$5.1M
Regulation of Fetal Skeletal Muscle Growth in IUGRR01HD079404 · NICHD · UNIVERSITY OF COLORADO DENVER · PI Laura Davidson Brown · 2015 to 2026
$4.7M
Nutrient and Insulin Metabolic Actions in IUGR Fetal LiverR01DK108910 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Stephanie R Wesolowski · 2017 to 2026
$4.3M
Physiological Ramifications of Chorionic Somatomammotropin DeficiencyR01HD093701 · NICHD · UNIVERSITY OF COLORADO DENVER · PI ANTHONY, RUSSELL V, ROZANCE, PAUL JOSEPH · 2018 to 2022
$2.9M
UV-visible HPLC with PCX Pinnacle post column reaction moduleS10OD023553 · OD · UNIVERSITY OF COLORADO DENVER · PI BROWN, LAURA DAVIDSON · 2017 to 2017
$98k
American Academy of Pediatrics (AAP) Marshall Klaus Perinatal Research Award NIH R01-753 HD079404American Academy of Pediatrics (AAP) Marshall Klaus Perinatal Research Award NIH R01-DK088139American Academy of Pediatrics (AAP) Marshall Klaus Perinatal Research Award NIH R01-DK108910American Academy of Pediatrics (AAP) Marshall Klaus Perinatal Research Award NIH R01-HD093701American Academy of Pediatrics (AAP) Marshall Klaus Perinatal Research Award NIH S10-OD023553American Academy of Pediatrics (AAP) Marshall Klaus Perinatal Research Award NIH T32HD007186HHS | National Institutes of Health (NIH) R01DK108910NICHD NIH HHS R01 HD079404NICHD NIH HHS R01 HD093701NICHD NIH HHS T32 HD007186NIDDK NIH HHS R01 DK088139NIDDK NIH HHS R01 DK108910NIH HHS S10 OD023553
6 · The paper itself

Abstract

key pointsFetal glucagon concentrations are elevated in the setting of placental insufficiency, hypoxia and elevated stress hormones. Chronically elevated glucagon concentrations in the adult result in profound decreases in amino acid concentrations and lean body mass. Experimental elevation of fetal glucagon concentrations in a late-gestation pregnant sheep results in lower fetal amino acid concentrations, lower protein accretion and lower fetal weight, in addition to decreased placental function. This study demonstrates a negative effect of glucagon on fetal protein accretion and growth, and also provides the first example of a fetal hormone that negatively regulates placental nutrient transport and blood flow. ABSTRACT: Fetal glucagon concentrations are elevated in the setting of placental insufficiency and fetal stress. Postnatal studies have demonstrated the importance of glucagon in amino acid metabolism, and limited fetal studies have suggested that glucagon inhibits umbilical uptake of certain amino acids. We hypothesized that chronic fetal hyperglucagonaemia would decrease amino acid transfer and increase amino acid oxidation by the fetus. Late gestation singleton fetal sheep received a direct intravenous infusion of glucagon (GCG; 5 or 50 ng/kg/min; n = 7 and 5, respectively) or a vehicle control (n = 10) for 8-10 days. Fetal and maternal nutrient concentrations, uterine and umbilical blood flows, fetal leucine flux, nutrient uptake rates, placental secretion of chorionic somatomammotropin (CSH), and targeted placental gene expression were measured. GCG fetuses had 13% lower fetal weight compared to controls (P = 0.0239) and >28% lower concentrations of 16 out of 21 amino acids (P < 0.02). Additionally, protein synthesis was 49% lower (P = 0.0005), and protein accretion was 92% lower in GCG fetuses (P = 0.0006). Uterine blood flow was 33% lower in ewes with GCG fetuses (P = 0.0154), while umbilical blood flow was similar. Fetal hyperglucagonaemia lowered uterine uptake of 10 amino acids by >48% (P < 0.05) and umbilical uptake of seven amino acids by >29% (P < 0.04). Placental secretion of CSH into maternal circulation was reduced by 80% compared to controls (P = 0.0080). This study demonstrates a negative effect of glucagon on fetal protein accretion and growth. It also demonstrates that glucagon, a hormone of fetal origin, negatively regulates maternal placental nutrient transport function, placental CSH production and uterine blood flow.

Indexed as

PlacentaPlacental InsufficiencyAnimalsFemaleFetal DevelopmentFetusGlucagonPregnancySheepGlucagonamino acidchorionic somatomammotropinfetal growthfetal leucine metabolismfick principleglucagonplacentatransplacental diffusion

Identifiers

PMID33878802
PMCPMC8249343
OpenAlexW3154114020

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.